Biotin-labeled anti-DNP Ab, PE-labeled streptavidin and HRP-conjugated streptavidin were purchased from Vector labs. DNP-conjugated keyhole limpet hemocyanin ( DNP KLH) and DNPconjugated bovine serum albumin ( DNP BSA) were purchased from Alpha Diagnostic International Inc.
5-Acetamido-9-amino-9-deoxy-3,5,9-trideoxy-D-glycero-r-D-galacto-2-nonulopyranosyl-onate (9-amino-Sia methyl ester) (3.2 g) was added to a flask containing DMF (10 ml), 2,4-dinitro-1-fluorobenzene (2 g) and triethylamine (2 ml). The solution was maintained at rt for 30 min with stirring and then concentrated by rotary evaporation. The residue was purified by silica gel chromatography eluted with methylene chloride/methanol (10:1) to afford DNP Sia methyl ester (2.5 g) in 51% yield. 1 H-NMR (500 MHz, CD 3 OD): δ 9.02 (1 H, d, J 2.6), 8.27 (1 H, dd, J 9.6, 2.6), 7.21 (1 H, d, J 9.6), 4.09 -4.01 (2 H, m), 3.97 (1 H, td, J 8.1, 3.2), 3.88 (1 H, dd, J 13.6, 3.2), 3.81 (1 H, d, J 9.6), 3.77 (3 H, s), 3.52 (2 H, m, J 12.4, 8.4), 2.24 (1 H, dd, J 12.9, 4.9), 2.01 (3 H, s), 1.95 -1.88
(1 H, m); 13 C-NMR (126 MHz, DMSO-d6): δ 175. 22, 171.67, 150.06, 136.91, 131.55, 131.01, 124.70 , 116.21 , 96.68 , 72.04 , 71.99 , 69.58 , 67.69 , 54.34 , 53.22 , 47.70 , 40.72 , 22.61; HRMS (C 18 To the solution of DNP Sia methyl ester (511 mg) in methanol (5 ml) was added 5 ml of aqueous NaOH (2 M). The solution was stirred at rt for 20 min and then neutralized with aqueous HCl (2 M) to neutral pH. The solution was concentrated and then purified by silica gel chromatography eluted with methylene chloride/methanol (2:1) to afford DNP Sia (250 mg) in 52% yield. 1 H NMR (500 MHz, CD 3 OD): δ 9.03 (d, 1H, J = 2.6), 8.30 (dd, 1H, J1 = 9.6, J2 = 2.6), 7.24 (d, 1H, J = 9.6), 4.04 (d, 2H, J = 10.5), 3.97 (dd, 2H, J1 = 20.3, J2 = 6.7), 3.87 (dd, 1H, J1 = 13.6, J2 = 3.2), 3.57-3.52 (m, 1H), 3.50 (d, 1H, J = 8.9), 2.16 (dd, 1H, J1 = 12.8, J2 = 4.7), 2.03 (s, 3H), 1.90 (t, 1H, J = 12.1); 13 C-NMR (126 MHz, CD 3 OD):
δ 176. 1, 173.3, 148.7, 135.5, 130.1, 129.7, 123.3, 115.0, 96.4, 70.6, 70.5, 68.3, 67.1, 52.6, 46.4, 40.4, 21.5; MS (C 17 Proparylamine (1 ml) and 2,4-dinitro-1-fluorobenzene (1.86 g) were added to acetonitrile (15 ml) containing N'N-diisopropylethylamine (1 ml). The solution was stirred for 2 h at 60 ℃and then cooled to give 2,4-dinitro-1-propargylaminobenzene as a high-purity yellow precipitation (1.8 g, 82% 130.89, 130.42, 123.82, 116.12, 79.78, 75.23, 32.82. To the solution of 9-azido-Sia methyl ester (1 g) and 2,4-dinitro-1-propargylaminobenzene (1 g) in tert-butanol (10 mL) were added sodium ascorbate (50 mg) and copper sulfate (10 mg) in water (5 ml).
The reaction mixture was refluxed at 80 ℃ for 24 h. The solvent was then lyophilized and the residue solid was purified by silica gel chromatography using methylene chloride/methanol (10:1) as the eluent to give DNP-Tz Sia methyl ester as a yellow solid (1 g, 59% 170.5, 147.9, 143.1, 136.0, 130.6, 129.7, 125.6, 124.4, 114.8, 95.3, 70.6, 70.2, 69.3, 66.2, 53.7, 52.8, 52.0, 39.4, 38.1, 21.3 
Western blot analysis of covalent incorporation of DNP Sia and DNP-Tz Sia into glycoconjugates
B16F10 cells were first cultured for 24 h in DMEM spiked with no sugar, DNP Sia (0.1, 1 mM) or DNPTz Sia methyl ester (0.1, 1 mM). The cells were collected, washed with PBS and then lysed with 1 ml of cell lysis buffer. The mixture were pelleted by centrifugation at 10,000 g for 10 min and the supernatant were diluted with lysis buffer to protein concentration of 1 mg ml -1 as determined by BCA protein assay.
The diluted samples were respectively added to 2 x SDS-PAGE loading buffer, resolved on 10% SDS-PAGE gels, transferred to nitrocellulose, and blocked with 5% bovine serum albumin in PBST (Dulbecco's Phosphate Buffered Saline with 0.05% Tween-20) for 1 h at 37 ℃. The blocked membrane was incubated with biotin-labeled anti-DNP Ab (1 μg ml -1 ) in blocking buffer for 2 h at 37 ℃, followed by HRP-conjugated streptavidin (1 μg ml -1 ) in blocking buffer for 2 h at 37 ℃, washed with PBST (3 x 10 min per wash), and developed using Super ECL Plus Chemiluminescent substrate.
Induction of anti-DNP antibodies in mice with DNP KLH
C57BL/6 mice were subcutaneously injected at the base of the tail with DNP KLH (50 μg) in 100 μl TiterMax Gold adjuvant (emulsions prepared according to the manufacturer's instructions). Two weeks later, Mice were further injected with 80% of the primary antigen dose injected on the back of the neck for 14 days after the first injection. The mice were maintained for following experiments.
ELISA analysis for anti-DNP Ab in mice
Blood samples were collected from the immunized mice and the levels of DNP-specific antibodies in the serum were analyzed by enzyme linked immunosorbent assay (ELISA) performed according to manufacturer's recommendation. Briefly, 96-well plates were coated with DNP-conjugated bovine serum albumin ( DNP BSA) at doses of 2 μg well -1 overnight and then blocked with 5% BSA in PBST for 1 h at 37
℃. The serum from immunized or control mice were collected 2 weeks after second immunization and diluted using PBS (1:10 4 ). 100 μL of diluted sera or PBS was added to each well, and the plate was incubated for 1 h at 37 ℃. The plate was washed with PBST and then incubated with a HRP-conjugated goat anti-mouse Ab (100 μL, 1:1000) for 1 h. The plates were washed four times with PBST, followed by addition of 200 μl/well of 3, 3', 5, 5'-tetramethylbenzidine (TMB). The enzymatic reaction was stopped after 5 min in the dark at rt by addition of H 2 SO 4 solution (2 M, 50 μL). The optical absorbance at 450 nm was determined using a SpectraMax Microplate Reader (Molecular Devices). Absorbance at 590 nm was measured. In addition, Cell number was determined by Trypan Blue Assay. Inhibiting B16F10 xenograft formation with intravenously injected DNP Sia B16F10 cells (2.5x10 6 ) were inocualted subcutaneously in immunized C57BL/6 mice for 3 days.
Effects of DNP Sia on cell proliferation
The resultant mice were treated with PBS (100 μl) or DNP Sia (30 mg kg -1 ) at 3 rd , 6 th and 9 th day after tumor transplantation. The tumor volumes in mice were measured over time (6-14 days after cell implantation).
Inhibition of pulmonary metastasis of B16F10 cells with surface-anchored DNP Sia
B16F10 cells were cultured in DMEM spiked without or with DNP Sia methyl ester (1 mM) for 24 h. ℃, stained with biotin-labeled DNP-specific Ab (10 μg ml -1 ) for 30 min at 37 ℃, washed with PBST and then stained with PE-labeled streptavidin (10 μg ml -1 ) for 30 min and DAPI (1 μM) for 15 min at 37 ℃, and then probed for ex vivo PE fluorescence.
Retention of DNP Sia in tumors in mice
A cohort of C57BL/6 mice bearing subcutaneous B16F10 tumors were injected intravenously with DNP Sia (60 mg kg -1 ) via tail vein. At 0-24 h following injection, the mice were anesthetized and the tumor were excised, washed with PBS, and then sectioned. The slices were blocked with 5% bovine serum albumin in PBST for 30 min at 37 ℃, stained with biotin-labeled DNP-specific Ab (10 μg ml -1 ) for 30 min at 37 ℃, washed with PBST and then stained with PE-labeled streptavidin (10 μg ml -1 ) for 30 min and DAPI (1 μM) for 15 min at 37 ℃, and then probed for ex vivo PE fluorescence. 
Cytotoxicity of DNP Sia in vivo
For cell toxicity: B16F10 cells were respectively cultured for 0-72 h in DMEM medium containing DNP Sia (0-1 mM) as described above. The cell number and cell viability were determined by MTT assay.
For systemic toxicity: Healthy mice were intravenously injected with DNP Sia (300 mg kg -1 ) via tail vein.
The mice were monitored regularly for adverse physiological effects. At 14 days post-injection, the mice were sacrificed and the tumor and selected organ was harvested, sectioned, and then stained with hematoxylin and eosin, and then recorded for visual images. 
